FRED KURLAND
CIK 1267273 · CFO · last filed 2023-06-15
FRED KURLAND is a CFO who has filed 27 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing, for ARDS, was dated Jun 15, 2023. Across all open-market trades the lifetime net is −$200.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.78M
2
27
-$200.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. (ARDS) Delisted | CFO | 4,000 | $0.31 | $1.2K | $0 | 7 | 2023-06-15 |
| XOMA | CFO & VP Finance | 114,461 | $41.79 | $4.78M | -$200.5K | 17 | 2015-04-07 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-15 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Mixed | +4,000 | $0 | EDGAR |
| 2022-12-07 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-29 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-01 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-12 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-11 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-07 | XOMA | Mixed | −5,337 | -$127.3K | EDGAR |
| 2015-03-20 | XOMA | Mixed | +1,712 | -$36.7K | EDGAR |
| 2015-03-02 | XOMA | Grant (A) | +10,000 | $0 | EDGAR |